Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-14

Clinical Trial Update: Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing dosing, safety and pharmacokinetics of rifabutin when co-administered with Kaletra (lopinavir/ritonavir) in children wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kaletra (lopinavir)
  • RIFABUTIN (Rifabutin)

Snippet

Sponsor: Harriet Shezi Children's Clinic | Conditions: Children With Confirmed HIV Infection, Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose | Phase 1 | Status: UNKNOWN